BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29773092)

  • 1. Preliminary Study on Drug Susceptibility Profile and Resistance Mechanisms to Macrolides of Clinical Isolates of Non-tuberculous Mycobacteria from China.
    Li F; Li GL; Pang H; Liu HC; Xiao TY; Li SJ; Luo Q; Jiang Y; Wang RB; Wan KL
    Biomed Environ Sci; 2018 Apr; 31(4):290-299. PubMed ID: 29773092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
    Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
    J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in
    Yoshida S; Tsuyuguchi K; Kobayashi T; Inoue Y; Suzuki K
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33570485
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex.
    Carneiro MDS; Nunes LS; David SMM; Barth AL
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):775-778. PubMed ID: 29091138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species.
    Jong BE; Wu TS; Chen NY; Yang CH; Shu CC; Wang LS; Wu TL; Lu JJ; Chiu CH; Lai HC; Chung WH
    Microbiol Spectr; 2022 Dec; 10(6):e0274922. PubMed ID: 36416559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A; Tato M; Broncano-Lavado A; Esteban J; Ruiz-Serrano MJ; Sánchez-Cueto M; Toro C; Domingo D; Cacho J; Barrado L; López-Roa P
    Microbiol Spectr; 2023 Jun; 11(3):e0504122. PubMed ID: 37212700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital.
    Chew KL; Cheng JWS; Hudaa Osman N; Lin RTP; Teo JWP
    J Med Microbiol; 2017 Oct; 66(10):1443-1447. PubMed ID: 28874233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
    Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
    Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
    Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
    Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility.
    Yoshida M; Sano S; Chien JY; Fukano H; Suzuki M; Asakura T; Morimoto K; Murase Y; Miyamoto S; Kurashima A; Hasegawa N; Hsueh PR; Mitarai S; Ato M; Hoshino Y
    EBioMedicine; 2021 Feb; 64():103187. PubMed ID: 33446475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates].
    Sürücüoğlu S; Özkütük N; Gazi H; Çavuşoğlu C
    Mikrobiyol Bul; 2023 Oct; 57(4):639-649. PubMed ID: 37885391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar.
    Christianson S; Grierson W; Kein D; Tyler AD; Wolfe J; Sharma MK
    PLoS One; 2016; 11(8):e0158723. PubMed ID: 27490181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.
    Bastian S; Veziris N; Roux AL; Brossier F; Gaillard JL; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2011 Feb; 55(2):775-81. PubMed ID: 21135185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Identification of Strains within the
    Kania K; Wόjcik K; Czekajewska J; Grzesiak M; Klesiewicz K
    Pol J Microbiol; 2023 Dec; 72(4):491-506. PubMed ID: 38103008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated drug resistance in mycobacteria: the tip of the iceberg?
    Derbyshire KM; Salfinger M
    J Clin Microbiol; 2023 Oct; 61(10):e0062823. PubMed ID: 37724858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.